Pravastatine [French] en es it fr

Pravastatine [French] Brand names, Pravastatine [French] Analogs

Pravastatine [French] Brand Names Mixture

  • No information avaliable

Pravastatine [French] Chemical_Formula


Pravastatine [French] RX_link

Pravastatine [French] fda sheet

Pravastatine_[French] FDA

Pravastatine [French] msds (material safety sheet)

Pravastatine [French] Synthesis Reference

A. Terahara, M.Tanaka, U.S. Pat. 4,346,227(1982)

Pravastatine [French] Molecular Weight

424.528 g/mol

Pravastatine [French] Melting Point


Pravastatine [French] H2O Solubility


Pravastatine [French] State


Pravastatine [French] LogP


Pravastatine [French] Dosage Forms


Pravastatine [French] Indication

For the treatment of hypercholesterolemia to reduce the risk of myocardial infarction.

Pravastatine [French] Pharmacology

Pravastatin, an antilipemic agent, is used to treat primary hypercholesterolemia. Unlike lovastatin and simvastatin, pravastatin is relatively hydrophilic and does not require hydrolysis for activation.

Pravastatine [French] Absorption

Average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.

Pravastatine [French] side effects and Toxicity

Rhabdomyolysis; LD50=mg/kg (orally in rat)

Pravastatine [French] Patient Information

Patients should be advised to report promptly unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever.

Pravastatine [French] Organisms Affected

Humans and other mammals